Bayesian modelling for COVID-19 seroprevalence studies
Por um escritor misterioso
Descrição
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study - The Lancet
Bayesian modelling for COVID-19 seroprevalence studies
Seroprevalence of SARS-CoV-2 Antibodies in Children and Adults in St. Louis, Missouri, USA
Explicit modeling of antibody levels for infectious disease simulations in the context of SARS-CoV-2 - ScienceDirect
Resurgence of SARS-CoV-2: Detection by community viral surveillance
Seropositivity in blood donors and pregnant women during the first year of SARS‐CoV‐2 transmission in Stockholm, Sweden - Castro Dopico - 2021 - Journal of Internal Medicine - Wiley Online Library
Substantial underestimation of SARS-CoV-2 infection in the United States
SARS-CoV-2 antibody seroprevalence follow-up in Malagasy blood donors during the 2020 COVID-19 Epidemic - eBioMedicine
Age-specific rate of severe and critical SARS-CoV-2 infections estimated with multi-country seroprevalence studies, BMC Infectious Diseases
Adjusting COVID-19 seroprevalence survey results to account for test sensitivity and specificity
Frontiers Modeling Early Phases of COVID-19 Pandemic in Northern Italy and Its Implication for Outbreak Diffusion
Serological evidence of human infection with SARS-CoV-2: a systematic review and meta-analysis - The Lancet Global Health
Dynamics of competing SARS-CoV-2 variants during the Omicron epidemic in England
de
por adulto (o preço varia de acordo com o tamanho do grupo)
